It is time to accelerate building local vaccine adjuvant manufacturing capacity

O’Hagan DT Fox CB. Are we entering a new age for human vaccine adjuvants? Expert Rev Vaccines 2015; 14: 909–911.

Reed SG Orr MT Fox CB. Key roles of adjuvants in modern vaccines. Nat Med 2013; 19: 1597–1608.

Gupta PV. Serum Institute produces over 1.2 billion vaccine doses annually. ETHealthWorld. New Delhi, 2017. http://health.economictimes.indiatimes.com/news/industry/serum-institute-produces-over-1-2-billion-vaccine-doses-annually/59124716 (accessed 28 July 2017).

Padmanabhan S Amin T Sampat B et al . Intellectual property, technology transfer and developing country manufacture of low-cost HPV vaccines: a case study of India. Nat Biotechnol 2010; 28: 671–678.

World Health Organization. Increasing access to vaccines through technology transfer and local production. Geneva: WHO, 2011.

Fox CB Huynh C O’Hara MK et al . Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania. Vaccine 2013; 31: 1633–1640.

Stavaru C Onu A Lupulescu E et al . Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant. Hum Vaccin Immunother 2016; 12: 1009–1026.

Ventura R Brunner L Heriyanto B et al . Technology transfer of oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia. Vaccine 2013; 31: 1641–1645.

Grohmann G Francis DP Sokhey J et al . Challenges and successes for the grantees and the Technical Advisory Group of WHO’s influenza vaccine technology transfer initiative. Vaccine 2016; 34: 5420–5424.

World Health Organization. Report of the ninth meeting with international partners on prospects for influenza vaccine technology transfer to developing country vaccine manufacturers. Geneva: WHO, 2016.

Multi Vaccines Development Program. P.vivax, PvDBPII, 2017. www.mvdp.org.in/P_vivax.php (accessed 28 July 2017).

Jayaraman K. India opens malaria vaccine center. Nat Med 2012; 18: 332–333.

National Institutes of Health. International research in infectious diseases, including AIDS (R01), PAR-17-142, 2017. http://grants.nih.gov/grants/guide/pa-files/PAR-17–142.html (accessed 28 July 2017).

World Health Organization. EDCTP-TDR clinical research and development fellowships, 2017. http://apps.who.int/iris/bitstream/10665/255301/1/WHO-HIS-TTi-17.4-eng.pdf (accessed 28 July 2017).

Nannei C Chadwick C Fatima H et al . Considerations for sustainable influenza vaccine production in developing countries. Vaccine 2016; 34: 5425–5429.

Kulkarni PS Socquet M Jadhav SS et al . Challenges and opportunities while developing a Group A meningococcal conjugate vaccine within a product development partnership: a manufacturer’s perspective from the Serum Institute of India. Clin Infect Dis 2015; 61: S483–S488.